23 Jul, 2026
According to Straits Research, the global biological safety testing products and services market, valued at $5.26 billion in 2025, is expected to grow from $5.81 billion in 2026 to $13.09 billion by 2034, at a CAGR of 10.68%.
The end-users of the biological safety testing products & services include pharmaceutical and biotechnology companies, contract development, and manufacturing organizations. Developing countries such as India and China are heavily investing in the healthcare infrastructure and research laboratories. Research laboratories offer extensive capacities such as drug discovery and cell line development and culture that require biologics safety testing to develop pathogen-free products and reliable services. The biological safety testing products and services require the expertise of the analysts to achieve optimal efficacy. However, the lack of skilled professionals might hamper the market growth to a certain extent.
Increasing focus on R&D activities accelerates the demand for biological safety testing products & services. The biologic safety testing products and services aids in avoiding cross-contamination, mix-ups, and leakage. Growth of the pharmaceutical and biotechnology industries drives the biological safety testing products and services market.
sales@straitsresearch.com